Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Regarding Shareholder Litigation & Info from TPL BK

At this time, I am not interested in any movement to sue the BoD. I would, however, be supportive of any justified effort on the part of our BoD to (1) bring legal action against Leckrone, (2)to use the BK Court to gain more control of PDS (3) to severe relationships with the entire Leckrone family once and for all.

At one time I had seen information from TPL's bankruptcy filing. From my notes, this is a partial listing and not all inclusive of what was in the filing:

Accts Receivable:

PDS (unknown portion of this is uncollectible) $2,866,678

Claim against PTSC for expense reimbursement for work on pending litigation $200,025

Claim against PTSC for expense " " " $152,817

Reimbursement due from PDS for certain MMP portfolio expenses Unknown

Unsecured Priority Claim

Janet Neal - incentive compensation $1,340,160

Unsecured Non Priority Claims

Alan Marsh MMP Revenue Share $457,687

Chester Brown " $10,028,429

Dan Leckrone " $9,012,285

John Leckrone " $9,012,285

Susan Anhalt " $9,012,285

PTSC Balance due on Settlement $1,042,500

Other transfers

Charles Moore 1/23/13 Debtor agreed Moore's percentage interest would be paid from PDS rather than TPL pursuant to a settlement agreement

Payments made to Creditors within 90 days of filing

Janet Neal $34,000

Janet Neal $62,617

PTSC 2/26/13 $8750

Janet Neal keeps popping up......hmmmm

Share
New Message
Please login to post a reply